IMC Chicago’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-12,204
| Closed | -$1.11M | – | 1326 |
|
|
2025
Q1 | $1.11M | Buy |
12,204
+1,821
| +18% | +$166K | ﹤0.01% | 281 |
|
|
2024
Q4 | $896K | Buy |
+10,383
| New | +$896K | ﹤0.01% | 404 |
|
|
2024
Q2 | – | Sell |
-20,854
| Closed | -$1.89M | – | 1053 |
|
|
2024
Q1 | $1.89M | Buy |
+20,854
| New | +$1.89M | ﹤0.01% | 131 |
|
|
2023
Q1 | – | Sell |
-23,245
| Closed | -$1.81M | – | 510 |
|
|
2022
Q4 | $1.81M | Sell |
23,245
-1,325
| -5% | -$103K | ﹤0.01% | 49 |
|
|
2022
Q3 | $1.65M | Sell |
24,570
-2,804
| -10% | -$189K | ﹤0.01% | 65 |
|
|
2022
Q2 | $2.1M | Buy |
27,374
+2,027
| +8% | +$156K | ﹤0.01% | 68 |
|
|
2022
Q1 | $2.02M | Buy |
25,347
+920
| +4% | +$73.4K | ﹤0.01% | 101 |
|
|
2021
Q4 | $1.88M | Buy |
+24,427
| New | +$1.88M | ﹤0.01% | 130 |
|
|
2020
Q4 | – | Sell |
-21,667
| Closed | -$1.35M | – | 423 |
|
|
2020
Q3 | $1.35M | Buy |
+21,667
| New | +$1.35M | ﹤0.01% | 85 |
|